STRATA CRITICAL MEDICAL, INC. APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
STRATA CRITICAL MEDICAL, INC. (SRTA) reported APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition of $3.71 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition · last filed 2026-08-04
- STRATA CRITICAL MEDICAL, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2026-06-30 was $3.71M, a 30.72% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2026-03-31 was $5.04M, a 19.40% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2025-12-31 was $6.65M, a 46.86% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2025-09-30 was $1.82M, a 66.22% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2025 was $18.04M, a 9.32% decline from fiscal 2024.
- STRATA CRITICAL MEDICAL, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2024 was $19.89M, a 59.13% increase from fiscal 2023.
- STRATA CRITICAL MEDICAL, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2023 was $12.50M.
- STRATA CRITICAL MEDICAL, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2021 was $8.61M.
| Period end | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.71M 10-Q · filed 2026-08-04 | $8.74M 10-Q · filed 2026-08-04 | $15.39M derived: sum of 3 quarters · filed 2026-08-04 | $17.21M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $5.04M 10-Q · filed 2026-05-06 | $11.68M derived: sum of 2 quarters · filed 2026-05-06 | $13.51M derived: sum of 3 quarters · filed 2026-05-06 | $18.86M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $6.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $8.47M derived: sum of 2 quarters · filed 2026-03-03 | $13.82M derived: sum of 3 quarters · filed 2026-08-04 | $18.04M 10-K · filed 2026-03-03 |
| 2025-09-30 | $1.82M 10-Q · filed 2025-11-10 | $7.17M derived: sum of 2 quarters · filed 2026-08-04 | $11.39M 10-Q · filed 2025-11-10 | $15.92M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $5.35M 10-Q · filed 2026-08-04 | $9.57M 10-Q · filed 2026-08-04 | $14.09M derived: sum of 3 quarters · filed 2026-08-04 | $19.49M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $4.22M 10-Q · filed 2026-05-06 | $8.74M derived: sum of 2 quarters · filed 2026-05-06 | $14.14M derived: sum of 3 quarters · filed 2026-05-06 | $19.79M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $9.93M derived: sum of 2 quarters · filed 2026-03-03 | $15.57M derived: sum of 3 quarters · filed 2026-03-03 | $19.89M 10-K · filed 2026-03-03 |
| 2024-09-30 | $5.40M 10-Q · filed 2025-11-10 | $11.05M derived: sum of 2 quarters · filed 2025-11-10 | $15.37M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $5.65M 10-Q · filed 2025-08-05 | $9.96M 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | $4.32M 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $12.50M 10-K · filed 2025-03-13 | |||
| 2021-12-31 | $2.93M 8-K · filed 2023-01-10 | |||
| 2021-09-30 | $8.61M 10-K · filed 2021-12-20 | |||
| 2020-12-31 | $1.03M 8-K · filed 2023-01-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |